mRNA name | UniProt accession | FPR | TPR | Publication | Orthologous group | Identification count All / Prokaryote / Eukaryote (FPR<0.05,TPR<0.5) |
---|---|---|---|---|---|---|
HRAS-like suppressor 3 (HRSL3) (EC 3.1.1.32) (EC 3.1.1.4) (Adipose-specific phospholipase A2) (AdPLA) (Group XVI phospholipase A1/A2) (H-rev 107 protein homolog) (HRAS-like suppressor 1) (HREV107-1) (HREV107-3) (Renal carcinoma antigen NY-REN-65) | P53816 | 0.0e+0 | 4.4e-1 | Identifying mRNA, microRNA and protein profiles of melanoma exosomes. PLoS One. 2012;7(10):e46874. doi: 10.1371/journal.pone.0046874. Epub 2012 Oct 9. | ENOG4111TDD | 8 / 0 / 8 |
HRAS-like suppressor 3 (HRSL3) (EC 3.1.1.32) (EC 3.1.1.4) (Adipose-specific phospholipase A2) (AdPLA) (Group XVI phospholipase A1/A2) (H-rev 107 protein homolog) (HRAS-like suppressor 1) (HREV107-1) (HREV107-3) (Renal carcinoma antigen NY-REN-65) | P53816 | 6.2e-9 | 4.8e-1 | Identifying mRNA, microRNA and protein profiles of melanoma exosomes. PLoS One. 2012;7(10):e46874. doi: 10.1371/journal.pone.0046874. Epub 2012 Oct 9. | ENOG4111TDD | 8 / 0 / 8 |
HRAS-like suppressor 3 (HRSL3) (EC 3.1.1.32) (EC 3.1.1.4) (Adipose-specific phospholipase A2) (AdPLA) (Group XVI phospholipase A1/A2) (H-rev 107 protein homolog) (HRAS-like suppressor 1) (HREV107-1) (HREV107-3) (Renal carcinoma antigen NY-REN-65) | P53816 | 2.0e-2 | 1.6e-1 | miR-1289 and Zipcode-like Sequence Enrich mRNAs in Microvesicles. Mol Ther Nucleic Acids. 2012 Feb 7;1:e10. doi: 10.1038/mtna.2011.2. | ENOG4111TDD | 8 / 0 / 8 |
HRAS-like suppressor 3 (HRSL3) (EC 3.1.1.32) (EC 3.1.1.4) (Adipose-specific phospholipase A2) (AdPLA) (Group XVI phospholipase A1/A2) (H-rev 107 protein homolog) (HRAS-like suppressor 1) (HREV107-1) (HREV107-3) (Renal carcinoma antigen NY-REN-65) | P53816 | 0.0e+0 | 2.6e-1 | Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc Natl Acad Sci U S A. 2013 Apr 30;110(18):7312-7. doi: 10.1073/pnas.1220998110. Epub 2013 Apr 15. | ENOG4111TDD | 8 / 0 / 8 |
HRAS-like suppressor 3 (HRSL3) (EC 3.1.1.32) (EC 3.1.1.4) (Adipose-specific phospholipase A2) (AdPLA) (Group XVI phospholipase A1/A2) (H-rev 107 protein homolog) (HRAS-like suppressor 1) (HREV107-1) (HREV107-3) (Renal carcinoma antigen NY-REN-65) | P53816 | 0.0e+0 | 2.5e-1 | Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc Natl Acad Sci U S A. 2013 Apr 30;110(18):7312-7. doi: 10.1073/pnas.1220998110. Epub 2013 Apr 15. | ENOG4111TDD | 8 / 0 / 8 |
HRAS-like suppressor 3 (HRSL3) (EC 3.1.1.32) (EC 3.1.1.4) (Adipose-specific phospholipase A2) (AdPLA) (Group XVI phospholipase A1/A2) (H-rev 107 protein homolog) (HRAS-like suppressor 1) (HREV107-1) (HREV107-3) (Renal carcinoma antigen NY-REN-65) | P53816 | 0.0e+0 | 3.3e-1 | The Three-Gene Signature in Urinary Extracellular Vesicles from Patients with Clear Cell Renal Cell Carcinoma. J Cancer. 2016 Sep 27;7(14):1960-1967. eCollection 2016. | ENOG4111TDD | 8 / 0 / 8 |
HRAS-like suppressor 3 (HRSL3) (EC 3.1.1.32) (EC 3.1.1.4) (Adipose-specific phospholipase A2) (AdPLA) (Group XVI phospholipase A1/A2) (H-rev 107 protein homolog) (HRAS-like suppressor 1) (HREV107-1) (HREV107-3) (Renal carcinoma antigen NY-REN-65) | P53816 | 0.0e+0 | 3.6e-1 | The Three-Gene Signature in Urinary Extracellular Vesicles from Patients with Clear Cell Renal Cell Carcinoma. J Cancer. 2016 Sep 27;7(14):1960-1967. eCollection 2016. | ENOG4111TDD | 8 / 0 / 8 |